Comparative Effectiveness of Physiotherapeutic Scoliosis-Specific Exercises With Idiopathic Scoliosis

April 20, 2026 updated by: Yavuz Yakut, Hasan Kalyoncu University

Comparative Effectiveness of Physiotherapeutic Scoliosis-Specific Exercises Versus General Exercises in Adolescents With Idiopathic Scoliosis: A Randomized Controlled Trial

This randomized controlled trial evaluates the effectiveness of Physiotherapeutic Scoliosis-Specific Exercises (PSSE-Schroth) compared with General Exercises in adolescents with idiopathic scoliosis over a 12-month intervention period. Primary outcomes include Cobb angle progression and brace prescription rate. Secondary outcomes include trunk rotation, quality of life, self-image, and body symmetry.

Study Overview

Detailed Description

Adolescent idiopathic scoliosis is a three-dimensional spinal deformity that may progress during growth. Although PSSE is increasingly recommended in conservative scoliosis management, comparative randomized evidence remains limited. This study aims to compare PSSE-Schroth exercises with General Exercises in adolescents with mild idiopathic scoliosis over 12 months. Participants are randomized into intervention or control groups receiving matched exercise dosage and supervision. Outcomes assess radiographic progression, trunk rotation, need for bracing, and patient-reported clinical parameters.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Şahinbey
      • Gaziantep, Şahinbey, Turkey (Türkiye), 27000
        • Hasan Kalyoncu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Diagnosis of adolescent idiopathic scoliosis

    • Cobb angle 10°-25°
    • Risser sign 0-3 ATR >5°
    • Less than 1 year post-menarche (for females)

Exclusion Criteria:

  • Previous brace treatment * Non-idiopathic scoliosis

    • Previous scoliosis surgery
    • Neuromuscular or congenital scoliosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PSSE-Schroth Group
Participants performed individualized PSSE-Schroth exercises based on curve pattern, including corrective breathing, postural correction, and ADL training.
Participants performed individualized PSSE-Schroth exercises based on curve pattern, including corrective breathing, postural correction, and ADL training
Active Comparator: General Exercise Group
Participants performed general strengthening and stretching exercises without scoliosis-specific correction.
Participants performed general strengthening and stretching exercises without scoliosis-specific correction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cobb Angle
Time Frame: Baseline to 12 Months
Cobb angle will be measured on standing anteroposterior spinal radiographs using the standard Cobb method. The angle is defined as the intersection of lines drawn parallel to the superior endplate of the upper-end vertebra and the inferior endplate of the lower-end vertebra of the primary curve. Measurements will be performed at baseline and after the intervention period, and the change in Cobb angle (in degrees) will be calculated. Lower values indicate an improvement in spinal curvature.
Baseline to 12 Months
Brace Prescription Rate
Time Frame: 12 Months
The proportion of participants requiring orthotic bracing during the study period will be recorded. Brace prescription will be determined by a specialist according to established clinical criteria (e.g., curve magnitude, skeletal maturity, and risk of progression). The rate will be expressed as the percentage of participants prescribed a brace in each group during the follow-up period.
12 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SRS-22 Questionnaire Score
Time Frame: Baseline to 12 Months
Health-related quality of life will be assessed using the Scoliosis Research Society-22 Questionnaire (SRS-22). This validated instrument includes five domains: function/activity, pain, self-image/appearance, mental health, and satisfaction with management. Each item is scored on a 5-point Likert scale, with higher scores indicating better health status. Assessments will be performed at baseline and after the intervention period, and changes in domain and total scores will be analyzed.
Baseline to 12 Months
TAPS Score
Time Frame: Baseline to 12 Months
Trunk appearance will be assessed using the Trunk Appearance Perception Scale (TAPS). This patient-reported outcome measure evaluates subjective perception of trunk deformity using a set of standardized drawings viewed from different perspectives. Each item is scored on a Likert scale, with higher scores indicating better perceived trunk appearance (less deformity). Assessments will be conducted at baseline and after the intervention period, and changes in TAPS scores will be analyzed.
Baseline to 12 Months
TRACE Score
Time Frame: Baseline to 12 Months
Clinical trunk deformity will be assessed using the Trunk Aesthetic Clinical Evaluation (TRACE) scale. This clinician-rated tool evaluates visible asymmetries of the shoulders, scapulae, waist, and hemithorax. Each domain is scored based on the severity of asymmetry, and a total score is calculated, with higher scores indicating greater aesthetic deformity. Assessments will be performed at baseline and after the intervention period, and changes in TRACE scores will be analyzed.
Baseline to 12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 18, 2024

Primary Completion (Actual)

November 18, 2024

Study Completion (Actual)

November 18, 2025

Study Registration Dates

First Submitted

April 20, 2026

First Submitted That Met QC Criteria

April 20, 2026

First Posted (Actual)

April 27, 2026

Study Record Updates

Last Update Posted (Actual)

April 27, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 825/2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe